Clinical trials: Volunteers on Chronic, Stable Antipsychotic Regimens
Volunteers on Chronic, Stable Antipsychotic Regimens
Staccato Loxapine Multidose PK
The objectives of this trial are to assess the safety, tolerability, and pharmacokinetics of multiple inhaled doses of Staccato Loxapine.
- Trial name
- NCT00555412
- Testing
- A - 10 mg loxapine q 4 h x 3 (30 mg total), B - 10 mg x 1, 5 mg x 2 loxapine q 4 h (20 mg total), C - 5 mg loxapine q 4 h x 3 (15 mg total)
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Alexza Pharmaceuticals, Inc.